VC firms invest £2.4m in BioBeats
A consortium of VC firms has invested ТЃ2.4m in London-based wellbeing device and application developer BioBeats.
IQ Capital, Oxford Sciences Innovation and White Cloud Capital led the round. The company had previously received investment from actor and rapper Will Smith and author Deepak Chopra.
The fresh capital will be used to roll out the company's product to a global audience.
Previous funding
A consortium of business angels including Will Smith led a seed round for BioBeats in 2013.
Axa Ventures, IQ and White Cloud joined the syndicate in 2014, providing a further $2m of funding.
Company
BioBeats was founded in 2012 and is headquartered in London. It develops wearable sensors that collect biometric data for health and wellbeing applications on a mobile device. The company uses the accrued data to recommend personalised stress and productivity management tools based on clinically proven coaching techniques.
People
IQ Capital – Ed Stacey (partner).
Oxford Sciences Innovation – Lilly Bussmann (principal).
BioBeats – David Plans (founder).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









